Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$81.24 - $97.37 $1.41 Million - $1.69 Million
17,400 Added 94.05%
35,900 $2.97 Million
Q1 2024

May 07, 2024

BUY
$71.24 - $85.35 $1.05 Million - $1.26 Million
14,800 Added 400.0%
18,500 $1.58 Million
Q4 2023

Feb 14, 2024

BUY
$80.59 - $92.61 $298,183 - $342,657
3,700 New
3,700 $316,000
Q2 2023

Aug 11, 2023

BUY
$80.84 - $89.45 $695,224 - $769,270
8,600 Added 318.52%
11,300 $962,000
Q1 2023

May 16, 2023

SELL
$72.75 - $90.6 $472,875 - $588,900
-6,500 Reduced 70.65%
2,700 $223,000
Q4 2022

Feb 14, 2023

SELL
$73.85 - $86.14 $3.27 Million - $3.82 Million
-44,300 Reduced 82.8%
9,200 $723,000
Q3 2022

Nov 14, 2022

BUY
$63.3 - $78.66 $2.83 Million - $3.52 Million
44,700 Added 507.95%
53,500 $3.96 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.05B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.